FIND Neuro: A New Direction in Epilepsy Management

Guiding Healthcare Decisions for Better Patient Outcomes

FIND Neuro: A New Direction in Epilepsy Management

Guiding Healthcare Decisions for Better Patient Outcomes

FIND Neuro: A New Direction in Epilepsy Management

Guiding Healthcare Decisions for Better Patient Outcomes

FIND Neuro is a pioneering platform
aimed at improving surgical outcomes
for Drug-Resistant Epilepsy patients.

3.4M People with Epilepsy

3.4 million Americans live with epilepsy, facing daily challenges and limitations.

1.2M People with Drug-Resistant Epilepsy

1.2 million struggle with Hard-to-Treat Epilepsy, not responding to standard medications and treatments.

30% - 80% Surgical success

Surgical success rates vary widely, ranging from 30% to 80%, highlighting the inconsistency in treatment outcomes.

Welcome to FIND Neuro, your new pathway to safer and more effective epilepsy treatment.

We‘re changing the approach to epilepsy surgery, reducing risks, and improving your chances of success.

By taking a complete look at the network of brain areas involved in seizures, our platform allows for surgeries that are more focused and less intrusive.

We pinpoint the most crucial areas in the brain network for seizures. This allows medical teams to opt for surgical or neuromodulation strategies that promise higher success rates.

When your healthcare center uses FIND Neuro, the decision to have epilepsy surgery becomes a lot less scary and much more reassuring.

Welcome to FIND Neuro, your new pathway to safer and more effective epilepsy treatment.

We‘re changing the approach to epilepsy surgery, reducing risks, and improving your chances of success.

By taking a complete look at the network of brain areas involved in seizures, our platform allows for surgeries that are more focused and less intrusive.

We pinpoint the most crucial areas in the brain network for seizures. This allows medical teams to opt for surgical or neuromodulation strategies that promise higher success rates.

When your healthcare center uses FIND Neuro, the decision to have epilepsy surgery becomes a lot less scary and much more reassuring.

1

Initial Analysis

We start by using medical imaging to create a comprehensive 4D view of the brain areas affected by seizures.

2

Network Study

Next, we look at brain connectivity and plan where to put sensors for more tests.

3

Database Matching

We use sensors to gather more info and match brain patterns with a large database.

4

Safe Treatment

Lastly, we use data comparisons to identify the most effective treatments, minimize risks, and avoid past mistakes.

Initial Analysis

We start by using medical imaging to create a comprehensive 4D view of the brain areas affected by seizures.

Network Study

Next, we look at brain connectivity and plan where to put sensors for more tests.

Database Matching

We use sensors to gather more info and match brain patterns with a large database.

Safe Treatment

Lastly, we use data comparisons to identify the most effective treatments, minimize risks, and avoid past mistakes.

For 6-year-old Alice,
each day involved up to 50 seizures.
Traditional treatments were hit or miss, with only a 20%-50% chance of success.

That changed when our algorithms pinpointed exactly where to treat,

completely eliminating her seizures.

FIND’s clinical decision support platform will enable our team to utilize our vast patient database to derive the most effective treatments for each patient.  By using this platform, I believe we will have the tools to improve further our surgical outcomes and reduce complications.

Noam Peled, Ph.D.

CEO
Co-Founder

Former faculty at the MGH/HST Martinos Center for Biomedical Imaging and Harvard Medical School.

Avi Yaron

Executive Chairman
Co-Founder

Founder, CEO, and Executive Chairman of Neurotech startups Set & led Joy Ventures and HealthYA Ventures ($50M AUM each).

Steven Stufflebeam, MD.

Chairman of the Scientific Advisory Board and Co-founder

Neuroradiologist, Associate Professor at Harvard Medical School, Medical Director of the Martinos Center and the MEG clinical core for epilepsy, MGH.

Adam P. Lerner, JD

COO, Head of Legal
Co-Founder

Former Vice President, Legal & Head of Intellectual Property at two VC-backed biotech companies.

Contact Us

If you have questions or require further details about our platform, don't hesitate to contact us.